Is Caffox (ergotamine and caffeine) safe to use during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 31, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Caffox (Ergotamine-Caffeine) is Absolutely Contraindicated in Pregnancy

Caffox must never be used during pregnancy under any circumstances. This is an FDA Pregnancy Category X medication, meaning it is contraindicated because it causes fetal harm 1.

Why This is Non-Negotiable

The FDA drug label explicitly states that ergotamine-caffeine is contraindicated in pregnancy due to multiple mechanisms of harm 1:

  • Oxytocic effects: Ergotamine stimulates uterine contractions, which are maximal in the third trimester and can precipitate labor 1
  • Vascular disruption: Prolonged vasoconstriction of uterine vessels and increased myometrial tone reduce placental blood flow, contributing to fetal growth retardation 1
  • Placental transfer: Both ergotamine and caffeine cross the placenta, with caffeine known to be teratogenic in animals 1

Evidence of Actual Fetal Harm

Real-world case reports and observational studies document serious adverse outcomes:

  • Vascular disruption defects: Jejunal atresia, arrested cerebral maturation, and paraplegia have been reported in infants exposed to ergotamine-caffeine combinations during pregnancy 2, 3
  • Growth restriction: A population-based study of 77 exposed pregnancies found mean birth weight decreased by 196g, with significantly increased rates of low birth weight (16.4% vs 5.7%) and preterm birth (16.4% vs 9.2%) 4
  • Acute fetal distress: Case reports document sudden fetal stress requiring emergency cesarean section after even single-dose maternal ergotamine exposure 5

What to Use Instead

Current guidelines from Nature Reviews Neurology (2021) provide clear alternatives for migraine in pregnancy 6:

First-line acute treatment:

  • Paracetamol (acetaminophen) - despite relatively poor efficacy, this is the safest option
  • NSAIDs - can be used ONLY during the second trimester; avoid in first and third trimesters

Second-line (specialist supervision only):

  • Triptans - limited safety data, mostly from sumatriptan post-marketing surveillance; use only under strict specialist supervision if absolutely necessary 6

For nausea:

  • Metoclopramide - acceptable during pregnancy 6

Critical Pitfalls to Avoid

  1. Do not assume "just one dose" is safe: Even single exposures have caused acute fetal distress 5
  2. Do not use in any trimester: The oxytocic effect is maximal in the third trimester, but vascular disruption can occur throughout pregnancy 1
  3. Caffeine component adds risk: The caffeine in Caffox (100mg per tablet) independently crosses the placenta and has been associated with miscarriage, low birth weight, and developmental effects even at doses below 200mg/day 7, 8, 9

The Bottom Line

The 2002 Headache Consortium guidelines note that "coexisting conditions (such as heart disease, pregnancy, and uncontrolled hypertension) may limit treatment choices" 10. For pregnancy specifically, ergotamine-caffeine combinations are not merely "limited"—they are absolutely prohibited. The FDA contraindication, supported by documented cases of fetal harm and population-level evidence of adverse outcomes, leaves no room for clinical judgment on this point.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.